Prof. Dr. Alaka Deshpande comments on WHO's latest recommendation for the use of Dolutegravir as the preferred first-line ARV for HIV positive patients. She also mentions that while NACO may follow in this direction, patient counselling and rigid adherence are still key to success.
Aug 21, 2019
Dr. Alaka Deshpande details on the significant damage that undiagnosed thyroid dysfunction can cause to the mother and foetus during pregnancy while outlining key practice points for physicians to adopt early on in order to prevent unfavourable outcomes.
May 08, 2019
Dr. Alaka Deshpande covers conditions to be ruled out before diagnosing subclinical hypothyroidism (SCH), management of SCH, and the ongoing debate on thyroxine therapy.
Mar 30, 2019
Prof. Dr. Alaka Deshpande, a Padmashree awardee and a WHO-recognised expert in dealing with HIV/AIDS shares quick notes on HIV diversity and circulating recombinant forms (CRFs).
Jan 03, 2019
World AIDS Day: Prof. Dr. Alaka Deshpande, expert on HIV/AIDS tells us why we cannot afford to be...
On this World AIDS Day, we have Prof. Dr. Alaka Deshpande, a Padmashree awardee and a WHO-recognised expert in dealing with HIV/AIDS sharing some important and practical advice that stems from her huge body of work from this area.
Dec 01, 2018